Back to results
US 2025/0049786 A1Published application
Dopamine d3/d2 receptor modulating compounds
AssigneeRichter Gedeon Nyrt.
InventorsIstván Borza, János Eles, Bálint Menczinger, Szilvia Bodnárné Deák
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for compounds of Formula (1): wherein R1 has any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions including schizophrenia. Also provided are pharmaceutical compositions comprising compounds of Formula (1).
Claims13
A compound of the general formula (I), or a pharmaceutically acceptable salt thereof,
- wherein
- R1 is straight chain C1-C3 alkyl.
Dependencies are inferred from the claim text.